In our study, the 4-month-old APP/PS1 mice did not exhibit notable cognitive deficits, while the 4.5-month-old APP/PS1 mice did not show obviously decreased synaptophysin or increased phosphorylated tau levels but displayed deposition of amyloid plaques, which is consistent with previous studies. The gene discussed is MAPT; the disease is Cognitive impairment.